A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to assess the safety and efficacy of NT 201 compared with placebo in participants with moderate to severe platysma prominence. The study will be conducted in two periods: Main Period (MP) and Open label Extension Period (OLEX).
Epistemonikos ID: 60e506deba59e4e3582ed5874b71a9d8088348e5
First added on: Aug 15, 2025